Unboosted atazanavir-based therapy maintains control of HIV type-1 replication as effectively as a ritonavir-boosted regimen-Reference-Cited by-同舟云学术

Unboosted atazanavir-based therapy maintains control of HIV type-1 replication as effectively as a ritonavir-boosted regimen

Published:2010 Issue:7 Volume:15 Page:993-1002
ISSN:1359-6535
Container-title:Antiviral Therapy
language:
Short-container-title:Antivir Ther

Author:

Ghosn Jade,Carosi Giampiero,Moreno Santiago,Pokrovsky Vadim,Lazzarin Adriano,Pialoux Gilles,Sanz-Moreno Jose,Balogh Agnes,Vandeloise Eric,Biguenet Sophie,Leleu Ghislaine,Delfraissy Jean-Francois

Publisher

SAGE Publications

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effects of pitavastatin on atherosclerotic-associated inflammatory biomarkers in people living with HIV with dyslipidemia and receiving ritonavir-boosted atazanavir: a randomized, double-blind, crossover study;AIDS Research and Therapy;2023-02-27

3. No difference in effectiveness of treatment simplification to boosted or unboosted atazanavir plus lamivudine in virologically suppressed in HIV-1-infected patients;PLOS ONE;2018-09-20

4. Abacavir/lamivudina + atazanavir no potenciado en la práctica clínica diaria: doce años de experiencia;Enfermedades Infecciosas y Microbiología Clínica;2018-01

5. Abacavir/lamivudine + unboosted atazanavir in routine clinical practice: Twelve years experience;Enfermedades infecciosas y microbiologia clinica (English ed.);2018-01